,129 To identify other factors that may predict CLD, we utilized multiplex protein assays and mass spectrometry to identify elevated serum concentrations of sCD163, CXCL12, and bile acids as markers of liver pathology in patients with end-stage HF. The gene discussed is CD163; the disease is hydrops fetalis.